Search
for
Sort by
Research 751–780 of 1000+
- 22. The effects of finasteride on behavioral changes in thioacetamide-induced hepatic encephalopathy in rats
- 2 Hair transplantation
- Abstract 1489: Basal cell carcinomas express functional indoleamine 2,3-dioxygenase (IDO) which may confer immunoprotection
- Matriptase-2, A Novel Suppressor of Hepcidin.
- Viewpoint 2
- C-2-3 GND-VIAを用いたX帯SiGe-MMIC増幅器(C-2. マイクロ波A(能動デバイス), エレクトロニクス1)
- Commentary 2
- Effect of androgen on VEGF and VEGFR-2(FLK-1/KDR) expression in rat corpus cavernous
- Chronic Toxicity Studies of the Potential Cancer Preventive 2-(Difluoromethyl)-<i>dl</i>-ornithine
- Preliminary Toxicity Profile of Arotinoids SMR-2 and SMR-6 in Male B6D2F1 Mice
- Topical Rice Bran Oil (Oryza sativa L.) Has The Same Effect With 2% Topical Minoxidil To Prevent Senile Alopecia Through Improved Vascular Endothelial Growth Factor (VEGF) Protein Expression, Hair Follicle Diameter And Length In Wistar Rats (Rattus norvegicus) Exposed To Ultraviolet B Light
- Regularities of Change Concentrations of Interleukin-17A, Interleukin-2 and Interleukin-10 in the Blood of People with Alopecia Areata before and after Treatment with Platelet-Rich Plasma
- 607 Cutaneous overexpression of cyclooxygenase-2 models androgenetic alopecia in adult mice
- SARS‐CoV‐2 & androgenic alopecia: exploring links!
- Paper 2. Epigallocatechin Gallate and Tannic Acid Based Formulations of Finasteride for Dermal Administration and Chemoembolization
- Application of 2-Chloro-7-Nitrobenzo-2-Oxa-1, 3-Diazol (NBDCL) for Spectrophotometric Determination of Finasteride in Pharmaceutical Formulation
- Faculty Opinions recommendation of A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
- A quantitative hair growth assessment in androgenetic alopecia after application of two cosmetic lotions versus 2% topical minoxidil
- 22
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- The Bio-Safety Concerns of Three Domestic Temporary Hair Dye Molecules: Fuchsin Basic, Victoria Blue B and Basic Red 2
- Docking and Molecular Dynamics Identify Leads against 5 Alpha Reductase 2 for Benign Prostate Hyperplasia Treatment
- Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells